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Abstract
Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many
NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naı ¨ve NK cells is
fundamentally triggered by cytokines or myeloid dendritic cells (mDC) in various modes. In this study, we synthesized 16 S-
[2,3-bis(palmitoyl)propyl]cysteine (Pam2Cys) lipopeptides with sequences designed from lipoproteins of Staphylococcus
aureus, and assessed their functional properties using mouse (C57BL/6) bone marrow-derived DC (BMDC) and NK cells. NK
cell activation was evaluated by three criteria: IFN-c production, up-regulation of NK activation markers and cytokines, and
NK target (B16D8 cell) cytotoxicity. The diacylated lipopeptides acted as TLR2 ligands, inducing up-regulation of CD25/
CD69/CD86, IL-6, and IL-12p40, which represent maturation of BMDC. Strikingly, the Pam2Cys lipopeptides induced mouse
NK cell activation based on these criteria. Cell-cell contact by Pam2Cys peptide-stimulated BMDC and NK cells rather than
soluble mediators released by stimulated BMDC induced activation of NK cells. For most lipopeptides, the BMDC TLR2/
MyD88 pathway was responsible for driving NK activation, while some slightly induced direct activation of NK cells via the
TLR2/MyD88 pathway in NK cells. The potential for NK activation was critically regulated by the peptide primary sequence.
Hydrophobic or proline-containing sequences proximal to the N-terminal lipid moiety interfered with the ability of
lipopeptides to induce BMDC-mediated NK activation. This mode of NK activation is distinctly different from that induced by
polyI:C, which is closely associated with type I IFN-inducing pathways of BMDC. These results imply that the MyD88 pathway
of BMDC governs an alternative NK-activating pathway in which the peptide sequence of TLR2-agonistic lipopeptides
critically affects the potential for NK activation.
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Introduction
Natural killer (NK) cells function in early defense against various
pathogens. Microbial pattern molecules activate NK cells by
stimulating pattern-recognition receptors (PRRs) in NK cells or
myeloid dendritic cells (mDC) [1]. mDC-mediated NK activation
occurs secondary to mDC maturation, and is competent to induce
NK-activating cytokines or mDC membrane molecules to
facilitate reciprocal activation of mDC and NK cells [1,2]. Toll-
like receptors (TLRs) and cytoplasmic pattern sensors are PRRs
that may be associated with mDC-mediated NK activation [1,3].
In mDC, TLR3 and cytoplasmic sensors, RIG-I/MDA5 usually
participate in driving NK activation in response to double-
stranded (ds)RNA [4–6].
Staphylococcus aureus, a versatile Gram-positive pathogen, is
reported to activate NK cells during infection [7]. S. aureus cell
wall components including peptidoglycan, lipoproteins, and
alanylated lipoteichoic acid, are inflammation inducers, and
provoke the activation of host immune cells [8]. S. aureus cell wall
pattern molecules are mainly recognized by cell-surface TLR2 and
cytoplasmic nucleotide-binding oligomerization domain 2 (Nod2)
in host cells, which signal the presence of bacterial infection. Mice
lacking TLR2 or the adaptor protein MyD88 are highly
susceptible to S. aureus infection [9]. The molecular basis by which
S. aureus activates host immunity has been investigated, and
lipoprotein, rather than lipoteichoic acid, is the main trigger of
immune stimulation [10] that preferentially activates TLR2 in
mouse cells. TLR2/MyD88 determines the pathway for activation
of macrophages in mice [11]. Lipoprotein also activates TLR2 in
human cells [12,13].
The functional properties of S. aureus lipopeptides have been
investigated in gene-disrupted mice [9,14,15]. TLR2, in concert
with TLR1 or TLR6, is involved in their recognition [16,17]. Two
adaptor proteins, TIRAP and MyD88, deliver TLR2 signals that
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These studies were mainly performed in mouse macrophages, and
results were essentially consistent with other biochemical studies
using macrophages [20,21]. Nonetheless, more complicated
regulation may occur in other immune-related cells, including
mDCs. Recent studies suggested that in mDCs, TLR2 and
MyD88 are involved in NK activation that is provoked by
bacterial pattern molecules [22,23]. Our previous results also
inferred that bacterial lipoproteins act as TLR2 agonists in mDC-
driven NK activation [24].
In mDCs, a subset of the antigen-presenting cells, the two major
arms of the innate immune signaling pathway, the MyD88 and
TICAM-1 (TRIF) pathways, function in the TLR signaling
[18,19]. In addition, cytokines including IL-12, IL-15 and IFN-
a/b, as well as DC-NK contact are involved in NK cell activation
[25,26]. TLR3 is a sensor of dsRNA and induces mDC
maturation via TICAM-1 [4,25]. A characteristic feature of
TLR3-TICAM-1-mediated mDC maturation is liberation of IL-
12, and, independent of IL-12, drives NK cell activation [4]. On
the other hand, what factors participate in TLR2-MyD88-
mediated mDC maturation to drive NK activation remains
largely unknown.
We identified lipopeptides from Triton X-114-solubilized S.
aureus cells [27,28]. Since S. aureus lacks lipoprotein N-acyltransfer-
ase, these lipoproteins are predicted to be S-[2,3-bis(palmitoyl)-
propyl]cysteines (Pam2Cys) [29]. Their diacylated structure was
confirmed by MS/MS spectrometry [28]. We annotated these
lipoproteins by function, which largely depends on their protein
sequence [30]. Based on these results, we chemically synthesized
16 Pam2Cys lipopeptides of 6–18 amino acids (a.a.) [30]. They
possessed TLR2 agonistic activity, but varied in their functional
potential to activate NF-kB and liberate TNF-a from human
PBMC [30], yet their NK activation potential has not been
determined.
This study shows that naı ¨ve NK cells are usually in a resting
state, and bacterial lipoproteins trigger mDC-mediated NK
activation in response to TLR2-derived cellular events. We found
that mDC maturation and NK activation are strongly modulated
by the amino acid (a. a.) sequence of TLR2 agonistic lipopeptides.
Results
Cytokines liberated from BMDC in response to Pam2
peptides
We synthesized 16 Pam2Cys-containing lipopeptides using S.
aureus lipoproteins as a reference [30], and designated them
Pam2Cys1-Pam2Cys16 (Table 1). Included as positive controls
were the diacyl lipopeptides Pam2CSK4 [31], designated as
Pam2CSK19 in this study, and its derivatives Pam2CSK
(Pam2Cys17), and Pam2CSK2 (Pam2Cys18). Pam2Cys17 was
used as a negative control, since this diacyl lipopeptide has
virtually no cytokine-inducing activity (Fig. 1). ELAM-luciferase
reporter assays were used to assess the NF-kB activation potential
of these lipopeptides at 10–500 nM, and a representative result for
100 nM is in Figure 1A. Pam2Cys18 and 19 showed high reporter
activity, but Pam2Cys17 did not (Fig. 1A). A series longer than 3 a.
a were essential for TLR2 stimulation. The level of TNF-a
liberated from mouse BMDC was largely comparable with that
induced by human PBMC (Table 1). Pam2Cys4, Pam2Cys13,
Pam2Cys15 and Pam2Cys16 exhibited relatively low NF-kB
activation and TNF-a production (Table 1, Fig. 1A).
IL-6 and IL-12p40 levels were determined by ELISA using the
supernatant of the media from bone marrow-derived DC (BMDC)
culture with the lipopeptides for 24 h. The cytokines were detected
at high levels in the cultures with lipopeptides, with the exception
of Pam2Cys17, Pam2Cys13, and Pam2Cys16 (Fig. 1B,C). The
cytokine contents of wells with BMDCs stimulated with
Pam2Cys13 and Pam2Cys16 were as low as the control
Pam2Cys17.
The degree of CD86 upregulation by the 16 S. aureus
lipopeptides was examined, and similar DC maturation profiles
were obtained by flow cytometer for all Pam2Cys tested (Fig. 1D),
suggesting BMDC maturation, as determined by CD86 up-
regulation, was independent of NF-kB activation or cytokine
liberation by these lipopeptides.
NK activation by Pam2Cys peptides
Previous reports suggested that TLR2 agonists can induce NK
activation [22–24]. To investigate whether the S. aureus lipopro-
teins had NK cell-activating activity, we added the Pam2Cys
peptides at 100 nM to BMDC/NK cultures as described
previously [4]. Three markers for NK activation [26] were
assessed: IFN-c production, up-regulation of NK surface markers,
and target B16D8 cell cytotoxicity by NK cells (Fig. 2). IFN-c was
generated in the supernatants (sup) in response to the lipopeptides
(Fig. 2A). However, Pam2Cys13, Pam2Cys15, and Pam2Cys16
showed significantly low potential for IFN-c induction as
comparable to Pam2Cys17. Cytotoxic activity was evaluated
using B16D8 cells as a target [4]. Again, Pam2Cys13, 15 and 16
did not induce effective killing (Fig. 2B). The other S. aureus
lipopeptides had sufficient killing activity: two simultaneously
generated examples are shown in Figure 2B.
The NK cell activation markers CD25 and CD69 were
analyzed by flow cytometry after co-culturing NK cells with
BMDC and Pam2Cys stimulants (Fig. 2C). Up-regulation of
Table 1. Pam2 lipopeptides used for this study.
No. Lipid Amino acid sequence TNF-a*
Pam2Cys1 Pam2 CANTRHSESDK ++
Pam2Cys2 Pam2 CGTGGKQSSDK ++
Pam2Cys3 Pam2 CGNGNKSGSDD ++
Pam2Cys4 Pam2 CSNIEIFNAKG +/2
Pam2Cys5 Pam2 CTTDKKEIKAY +++
Pam2Cys6 Pam2 CSFGGNHKLSS ++
Pam2Cys7 Pam2 CGSQNLAPLEE +++
Pam2Cys8 Pam2 CGQDSDQQKDG +++
Pam2Cys9 Pam2 CGNDDGKDKDG +++
Pam2Cys10 Pam2 CGNNSSKDKEA +++
Pam2Cys11 Pam2 CSLPGLGSKST +++
Pam2Cys12 Pam2 CSTSEVIGEKI ++
Pam2Cys13 Pam2 CPFNCVGCYNK +/2
Pam2Cys14 Pam2 CGSQNLAPLEEK +/2
Pam2Cys15 Pam2 CLILIIASETL +/2
Pam2Cys16 Pam2 CLILIIASETLFSFSHLTDVK +/2
Pam2Cys17 Pam2 CSK n.d.
Pam2Cys18 Pam2 CSKK n.d.
Pam2Cys19 Pam2 CSKKKK ++
*100 pg/ml of Pam2 peptides were used for stimulation of PBMC.
TNF-a levels: +/2; ,200, ++; 2,000–4,000, +++; 4,000–7,000 pg/ml.
n.d., not determined.
doi:10.1371/journal.pone.0012550.t001
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PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12550Figure 1. Synthetic Pam2Cys lipopeptides activate TLR2 and induce cytokine production in BMDC. (A) HEK293 cells were transfected
with plasmids encoding TLR2 and ELAM-luciferase reporter. After 24 h, the cells were treated with Pam2Cys peptides (100 nM) for 6 h and then
luciferase activities of the cell lysates were measured. (B, C) BMDC were treated with Pam2Cys peptides for 24 h and IL-6 and IL-12p40 concentrations
in the culture supernatants were measured by ELISA. (D) CD86 and MHC class II (I-Ab) expression of the BMDC were determined by flow cytometry.
Data represents the mean 6 SD of triplicate measurements. The data shown are representative of at least three independent experiments. The
numbers represent the Pam2Cys’s numbers.
doi:10.1371/journal.pone.0012550.g001
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PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12550Figure 2. Pam2Cys peptides activate NK cells via BMDC. (A) Wild-type BMDC and wild-type NK cells were co-cultured at 1:2 ratio in the
presence of Pam2Cys peptides as the numbers indicated (100 nM). After 24 h, IFN-c concentrations in the supernatants were measured by ELISA. (B)
NK cell cytotoxicity against B16D8 cells was measured by
51Cr release assay at indicated E:T ratios as described in the Methods section. (C) Populations
of CD25+ and CD69+ NK cells were measured by flow cytometry after stimulation of NK cells with BMDC treated with indicated Pam2Cys peptides.
BMDC were stimulated with control PBS, 100 nM of Pam2Cys13 or Pam2Cys19 for 4 h. Then, BMDC were incubated with NK cells. After 24 h, cells
were analyzed by flow cytometer using the markers for separation. %Positive cells are shown to the right.
doi:10.1371/journal.pone.0012550.g002
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BMDC and Pam2Cys18 or 19, while the levels of their up-
regulation by Pam2Cys13, 15 or 16 were near those of the
negative control Pam2Cys17, for stimulating NK cells co-cultured
with BMDC. In contrast, no increase was observed for CD56,
NKp46 and DNAM-1 (data not shown).
Participation of TLR2/MyD88 in Pam2Cys-mediated
BMDC and NK activation
Activated NK cells are a major source of IFN-c, which causes a
variety of responses in the immune system. To examine whether
direct stimulation of NK cells with Pam2Cys18 or Pam2Cys19
induced secretion of IFN-c, we measured the frequency of IFN-c-
secreting NK cells, at 24 h after incubation. By intracellular
staining, IFN-c-secreting NK cells were increased after direct
Pam2Cys18 or 19 stimulation (data not shown). As shown in
Figure 3A and B, TLR2 ligands except Pam2Cys12, 18 and 19
barely increased the levels of IFN-c of NK cells by co-culture with
Pam2Cys-stimulated TLR22/2 or MyD882/2 BMDC. On the
other hand, NK cells induce moderate levels of IFN-c in response
to BMDC stimulated with Pam2Cys12, 18 or 19 (open bars in
Figure 3A), although no structural similarity was detected between
Pam2Cys12 and Pam2Cys18 or 19.
We next examined whether lipopeptide-mediated cytokine
secretion and NK activation were dependent on BMDC TLR2
and MyD88. IL-6 and IL-12p40 secretion were completely
abrogated in TLR22/2 BMDC (data not shown). However,
low amounts of IFN-c were detected in co-cultures of TLR22/2
or MyD882/2 BMDC and wild-type (WT) NK cells in the
presence of Pam2Cys12, 18, or 19 (Fig. 3B,D), and lesser extent of
IFN-c was still detected in co-cultures of WT BMDC and
TLR22/2 NK cells in the presence of Pam2Cys12 or
Pam2Cys19 (Fig. 3C). These results were reproduced with
MyD882/2 BMDC (not shown). Notable results are shown in
Fig. 3D where WT or TLR22/2 BMDC were stimulated with
indicated Pam2Cys and incubated with WT or TLR22/2 NK
cells. Moderate IFN-c was detected in the media containing
TLR22/2 BMDC, WT NK and Pam2Cys12 or 19 (Fig. 3D), the
IFN-c levels being comparable to those of WT NK cells alone
stimulated with Pam2Cys12 or 19 (Fig. S1). TLR22/2 NK cells
still produced very low levels of IFN-c when the TLR22/2 NK
cells were co-cultured with WT BMDC (Fig. 3D). However, No
IFN-c was detected in the media containing TLR22/2 NK and
Pam2Cys12 or 19. Thus, all Pam2Cys peptides including
Pam2Cys12, 18 and 19 act on BMDC to drive NK activation.
Notably, WT NK cells alone produce minute IFN-c in response to
Pam2Cys12 or 19 (Fig. S1), which means that Pam2Cys12 and
Pam2Cys19 additionally induce direct NK activation. The
Pam2Cys receptors for this NK activation is through the NK cell
TLR2 followed by the MyD88 pathway. However, minute
activation by Pam2Cys12 or 18/19 appears to be left in
TLR22/2 NK cells stimulated with Pam2Cys12/19-treated
BMDC, which should be attributed not to TLR2 but to other
unknown mechanisms.
Combinatorial recognition of Pam2Cys lipopeptide by
TLR2 and TLR6
TLR2 recognizes diacyl lipopeptides in combination with TLR6
[14,31] while TLR2 recognizes triacyl lipopeptide with TLR1
[15,32]. We found TLR2/6 cooperation in the recognition of S.
aureus lipopeptides using HEK293 cells that express TLR2/6. Data
on the use of TLR2/6 by Pam2Cys12, Pam2Cys13, Pam2Cys15,
Pam2Cys16, and Pam2Cys19 is shown in Figure 4. Single
receptors of TLR1, TLR6, and TLR10 showed little activation
of NF-kB by reporter assay, and only TLR2 exhibited ,60-fold
ELAM promoter activation (data not shown). Pam2Cys12 and
Pam2Cys17 more efficiently activated the ELAM promoter (.300
fold over the control) with TLR2 and 6, than with TLR2 alone
(Fig. 4A). TLR1 or TLR10 in combination with TLR2 did not
amplify the signal (Fig. 4B). Pam2Cys13 only weakly enhanced the
TLR2 potential with additional TLR6 expression in HEK cells
(Fig. 4A), and only a slight increase was observed with Pam2Cys15
and Pam2Cys16 with simultaneous expression of TLR2 and
TLR6 (Fig. 4A). Hence, TLR6 helped TLR2 to amplify the TLR2
signal from most Pam2Cys lipopeptides, but not with Pam2Cys13
or Pam2Cys15/16.
Critical a.a. in Pam2Cys lipopeptides for BMDC-mediated
NK activation
Recent studies revealed an extensive cross-talk between NK
cells and mDCs [2,6]. We analyzed the structural background that
supports NK activation using our synthetic diacyl lipopeptides. All
NK-activating lipopeptides tested had Cys-Ser/Thr or Cys-Gly/
Ala in their N-terminus (Table 1). However, the two lipopeptides
with the lowest ability to activate NK cells had differences, with
Cys-Pro in the N-terminus of Pam2Cys13, and Cys-Leu-Ile in
Pam2Cys15/16. When the second Pro in Pam2Cys13 was
replaced with Ser, and the Leu-Ile sequence of Pam2Cys16 was
replaced with Ser-Asn, the newly synthesized peptides, Pam2-
Cys13(P-S) and Pam2Cys16(LI-SN), recovered their ELAM
reporter activity (Fig. 5A).
We next tested whether BMDC mature to activate NK cells
through BMDC’s TLR2 activation by these modified Pam2Cys.
Pam2Cys13(P-S) and Pam2Cys15(LI-SN) recovered NK-activat-
ing properties by the amino acid conversions judged by IFN-c
production (Fig. 5B) and cytotoxicity against B16D8 cells (Fig. 5C).
Since Pam2Cys13(P-S) acts only on BMDC (not shown), this
Pam2Cys activity is attributable to recovered BMDC maturation.
Hence, Pam2Cys13(P-S) and Pam2Cys16(LI-SN) are NK activa-
tors via mDC TLR2. Hence, we conclude that the peptide
sequence near the N-terminus is important for NK activation by
diacyl lipopeptide.
Production of both IL-6 and IL-12p40 was dependent on
BMDC TLR2 (Fig. 6A). Pam2Cys13 and Pam2Cys16 induced
these cytokines at very low levels. When Pam2Cys13(P-S) or
Pam2Cys16(LI-SN) replaced Pam2Cys13 or Pam2Cys16 in the
same assay system, the cytokine levels recovered to levels similar to
those of the other lipopeptides (Fig. 6B). These activities were
almost completely abrogated in TLR22/2 BMDCs. Thus, the
a.a. replacements allows BMDC to generate the TLR2 signal,
irrespective of their artificial modifications.
BMDC-NK contact is indispensable for BMDC
TLR2-mediated NK activation
Pam2Cys13(P-S) matured BMDC to activate NK cells without
direct action on NK cells (Fig. 7A). First, we collected the sup of
BMDC stimulated with Pam2Cys13 or Pam2Cys13(P-S). Surpris-
ingly, Both of the sup failed to confer NK activating function on
the mixture of naı ¨ve BMDC and NK cells (data not shown). The
capacity of BMDC sup to induce IFN-c-secretion by NK cells was
further evaluated using a transwell system (Fig. 7A,B). No
significant increase in IFN-c-secreting NK cells was observed
when lipopeptide-activated BMDCs and NK cells were separated
by transwell (Fig. 7A,B). Frequency of IFN-c-producing NK cells
was high in co-culture with Pam2Cys13(P-S)-stimulated BMDC
and NK cells (Fig. 7B upper panel) while the IFN-c-producing NK
NK Activation by Pam2
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either case, IL-15 and IFN-a/b were barely increased in
Pam2Cys-stimulated BMDCs by RT-PCR (data not shown).
Thus, soluble factors barely participate in BMDC-mediated NK
activation. BMDC-NK contact is essential for TLR2-mediated
NK activation.
Discussion
Here, we demonstrated that the a. a. sequence of S. aureus
Pam2Cys peptides critically affects the agonistic function for
TLR2 and the mode of NK activation. This NK activation is
largely dependent on TLR2/MyD88 in BMDC in the mouse
Figure 3. TLR2 on BMDC mainly participate in Pam2Cys-mediated NK activation. (A) BMDC TLR2-independent NK activation by
Pam2Cys12, 18 and 19. BMDC from wild-type (closed bars) or TLR22/2 (open bars) mice were stimulated with control PBS or 100 nM of indicated
Pam2Cys peptides for 4 h. Cells were then co-cultured with wild-type NK cells at 1:2 ratio for 24 h. Then, the supernatants were collected and IFN-c
was measured by ELISA. (B) Pam2Cys12 and 19 induce NK activation in culture with MyD882/2 BMDC. NK cells were co-cultured with wild-type or
MyD882/2 BMDC in the presence of the indicated Pam2Cys peptides (represented by the numbers) as in Fig. 2. 24 h after incubation, culture media
were collected to determine cytokines by ELISA. (C) Pam2Cys12 and 19 induce TLR22/2 NK activation in culture with wild-type BMDC. Wild-type
BMDC and NK cells with either wild-type or TLR22/2 phenotype were incubated at 1:2 ratio with the indicated Pam2Cys peptides (represented by
the numbers) as in Fig. 2. 24 h after incubation, culture media were collected to determine cytokines by ELISA. One representative of the three similar
experiments is shown. (D) TLR2 NK cells mainly participates in TLR2 BMDC-independent NK activation by Pam2Cys12 and 19. Wild-type and TLR22/2
BMDC were stimulated with indicated Pam2Cys peptides for 4 h. These BMDC were then mixed with NK cells as shown in the panel. Four groups
consisting of either of wild-type NK or TLR22/2 NK and either of wild-type BMDC or TLR22/2 BMDC (see the bottom of the panel) were incubated
with the indicated Pam2Cys peptides (50 nM) for 24 h. NK cells alone with Pam2Cys12 or 19 liberated minure IFN-c as in the panel with WT NK +
TLR22/2 BMDC (see Fig. S1). IFN-c concentrations in the culture supernatants were determined by ELISA. The data shown are representative of at
least three independent experiments.
doi:10.1371/journal.pone.0012550.g003
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ability to directly activate NK cells without participation of
BMDC. In contrast, we determined Pam2Cys13, Pam2Cys15, and
Pam2Cys16 to be dysfunctional, since these lipopeptides failed to
activate TLR2/6 reporter signaling or induce cytokines in BMDC
(Fig. 1,4). Although the first Cys is conserved in all the lipopeptides
tested, the following sequences varied, even though all showed
BMDC maturation activity. Notably, the second a. a. residue was
Ser/Thr or Gly/Ala in the functional lipopeptides, followed by
undefined sequences. A length of more than three a.a. was
indispensable for BMDC-mediated NK activation (Fig. 1,
Pam2Cys17 vs. 18). The failure of Pam2Cys13, Pam2Cys15,
and Pam2Cys16 to activate NK cells suggests the importance of
the second and/or third residue for stimulating BMDC or
directing NK activation. Pam2Cys13 harbors Pro in the second
residue, which breaks hydrogen bond interactions. Likewise,
Pam2Cys15 and Pam2Cys16 commonly possess Leu and ILe in
the second and third residues, which also destabilize hydrogen
bond interactions. Thus, these a. a. residues critically influence the
effectual interaction between the Pam2Cys peptides and the TLR2
complex on either BMDC or NK cells.
TLR2 initiates immune response by recognizing diacylated
lipoproteins in combination with TLR6. We surmise that this
receptor complex recognizes the a. a. properties in the peptide
sequence that activate mDC/NK cells. Crystal structure analysis
indicates that hydrogen bonds between glycerol and the peptide
backbone of the ligand and the leucine-richrepeat (LRR)11 loops of
TLRs are critical for TLR heterodimerization [31,32]. These
hydrogen bonds bridge TLR2 and TLR6 with the ligand, and fix
the conformation of the hydrophobic residues around the
dimerization interface [31]. The side chains of the first two a. a.
of Pam2Cys have substantial interactions with the TLRs. The N-
terminal Cys binds to the sulfur site formed by the hydrophobic
F325, L328, F349, L350, and P352 residues of TLR2, and the L318
residue of TLR6 [31]. The hydroxyl side chains of the second Ser/
Thr form a medium-range hydrogen bond with the F325 backbone
of TLR2. As seen in the TLR2/TLR6/Pam2CSK4 structure, the
side chains beyond the third lysine residue have highly flexible
structures and form only weak ionic or hydrogen bond interactions
withthe TLRs [31]. Hence, our results with a. a. substitutions fit the
proposed TLR2-Pam2CSK4 interacting model.
In a previous report, lysines in the triacyl peptide were seen to
form hydrogen bonds with TLRs when Pam3CSK4 interacts with
TLR2/TLR1 heterodimer [32]. The e-amino residues in the side
chains appear to participate in lipopeptide recognition by TLRs
[31,32]. In our results, the small side chains of Asn or Gly had no
blocking effects on the peptide-TLR2 interaction (data not shown).
Thus, a hydrophilic or small a. a. in the chain barely altered the
lipopeptide function exerted through TLR2. The S. aureus
lipopeptides, with the exception of Pam2Cys13, Pam2Cys15,
and Pam2Cys16 are compatible with this principle. We actually
demonstrated here that the peptide sequences have a significant
effect on the immunological activity of the lipopeptides. The
recognition system for bacterial lipoproteins has developed to
Figure 4. TLR6 promotes TLR2 signaling in Pam2Cys peptides recognition. (A, B) HEK293 cells were transfected with plasmids encoding
TLR2, TLR6, TLR1 or TLR10 and the ELAM-luciferase reporter. After 24 h, the cells were treated with indicated Pam2Cys peptides (100 nM) for 6 h and
then luciferase activities were measured. The data shown are representative of at least three independent experiments.
doi:10.1371/journal.pone.0012550.g004
NK Activation by Pam2
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sequences.
The factor that determines whether mDC TLR2 or NK TLR2
predominates in diacyl lipopeptide activation has remained to be
settled. The sequence information about the NK-activating vs.
DC-activating lipopeptides in this study suggests that lysines or
hydrophilic a. a distal to Pam2Cys are involved in this selective
activity. Peptides with lysines tended to exert direct NK activation.
According to the structural studies [31,32], the lysines in
Pam3CSK4 form multiple hydrogen bonds with TLR2/1, and
the same is expected to be true of Pam2CSK4 and TLR2/6.
Hence, hydrophilic residues after the second residue of the
Pam2Cys lipopeptides may participate in high affinity interaction
with NK cell TLR2/6.
In a previous report, we identified the NK-activating protein
INAM, which discrminates between active and resting NK cells,
and reflects in vivo tumoricidal action of NK cells [33]. INAM is
expressed on polyI:C-matured mDCs in response to IRF-3
activation, and is not expressed on mDCs stimulated with TLR2
agonists [33]. In both TLR2- and TLR3-stimulation, IFN-c is a
marker of NK activation [4,6,22,33], almost parallel to NK cell-
mediated target cytotoxicity. According to these criteria, mDC
drive NK activation via two arrays, MyD88 and TICAM-1
pathways. Anyhow, the MyD88-mediated NK activation occurs
independently of TICAM-1-mediated NK activation. Here we
provide further knowledge on the MyD88-mediated NK activa-
tion: mDC TLR2-dependent, and mDC TLR2-independent
pathways exist for NK activation. The latter involves NK
TLR2-dependent NK activation, where the lipopeptides directly
stimulate TLR2 and the MyD88 pathway in NK cells. However, a
minimal NK-activating capacity by Pam2Cys12, 18 and 19 retains
in TLR22/2 NK cells. This means that the direct NK activation
largely depends on NK cell TLR2/MyD88 but does not neglect
participation of other undetermined factors, such as NOD-like
receptor (NLR) family, either in mDC or NK cells.
Pam2Cys-matured BMDC produce IL-12 by the MyD88
pathway. Unexpectedly, however, results from transwell studies
did not support the importance of IL-12 in NK activation. In
addition, NK-activating cytokines, such as IL-15 and IFN-a/b, are
barely increased in Pam2Cys-stimulated BMDC (data not shown).
Cell-cell contact rather than soluble mediators is crucial for mDC
TLR2-mediated NK activation in this study.
Taken together, we showed that S. aureus lipopeptides induce
mDC-mediated NK activation. It is intriguing that this is a case of
the reported reciprocal activation [2], in which ligands-receptors
on mDC and NK cells are involved. In a. a. sequences of
Pam2Cys, lysine distal to the N-terminal Pam2 and hydroxyl
residues proximal to the Pam2 affect NK-activating potential
through its interaction with TLR2. When bacteria invade host
tissue, they encounter many proteases. Since plasma serine
proteases frequently cleave the Lys-X sequence of substrates, the
lipoproteins may be clipped out into liberated lipopeptides
containing Lys, which could be important in the context of
TLR2-induced inflammatory immune responses. In fact, after
completing this manuscript, two in press papers were released
where some bacterial components are shown to participate in
TLR2-mediated NK activation [34,35]. Our findings furthered
these notions by analyzing synthetic Pam2Cys peptides under the
knowledge of the structural background of TLR2 [31,32].
A question remaining is why bacteria provide two sorts of
lipopeptides with TLR2-activating and –nonactivating properties.
So far, we have no experimental finding to sufficiently answer this
question, but bacterial infection usually alters host inflammatory
milieu and recruits immune competent cells to the lesion [36]. In
this context, it is not surprising that Pam2Cys lipopeptides serve as
modifiers for host immune response against bacteria. Different
responses could be expected to occur with various combinations of
Pam2Cys peptides in infectious lesion. Here we demonstrate that
Figure 5. Amino acids near the Pam2 lipid are critical for TLR2
recognition. (A) HEK293 cells were transfected with plasmids
encoding TLR2 and the ELAM-luciferase reporter. After 24 h, the cells
were treated with indicated Pam2Cys peptides (100 nM) for 8 h and
then luciferase activities were measured. The numbers represent the
Pam2Cys’s numbers. 13(P-S), Pam2Cys13 with second Proline replaced
with Serine; 15(LI-SN), Pam2Cys15 with second Leucine and third
Isoleucine replaced with Serine and Asparagine. (B,C) BMDC-mediated
NK cell activation occurs by stimulation with Pam2Cys13 (P-S) and
Pam2Cys15 (LI-SN). BMDC and NK cells were prepared from wild-type
mice. BMDC were stimulated with PBS or indicated Pam2Cys peptides
for 4 h. Then, BMDC were incubated with wild-type NK cells for 24 h.
IFN-c production (A) and B16D8 cytotoxicity (E:T ratio=50:1) (B) were
measured as in Figure 2. 13S and 15SN represent Pam2Cys13(P-S) and
Pam2Cys15(LI-SN), respectively.
doi:10.1371/journal.pone.0012550.g005
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bacterial lipopeptides, which properties are determined by the
peptide sequence of the Pam2Cys. Studies on these functional
behaviors of lipopeptide towards mDC and on how TLR signals
link NK activation in bacterial infectious diseases will be the next
highlight for understanding the importance of early phase of
innate cellular response against various bacterial infections.
Materials and Methods
Reagents and antibodies
The following materials were obtained as indicated: Fetal calf
serum (FCS) from Bio Whittaker (Walkersville, MD), mouse
granulocyte-macrophage colony-stimulating factor (GM-CSF)
from PeproTech EC, Ltd (London, UK), polymyxin B from
SIGMA-Aldrich (St. Louis, MO), Pam2CSK4 was in part
purchased from Amersham Pharmacia Biotech (Piscataway, NJ)
and Lympholyte-M from Cedarlane (Ontario, Canada). The
enzyme-linked immunosorbent assay (ELISA) kits for mouse
(m)IFN-c from eBioscience (San Diego, CA), and IL-12p40 and
IL-6 from Amersham Biosciences.
The following antibodies were used: mAbs against mouse
CD11c, NK1.1, CD86, I-Ab, CD25, CD69, DNAM1, CD56 and
NKp46 were purchased from BioLegend (San Diego, CA).
Preparation of synthetic peptides
The synthesis of lipopeptides was achieved with a combination
of solution- and solid-phase methods [30]. Briefly, for the
preparation of the Pam2Cys backbone, the protected cysteine
(Fmoc-Cys-OtBu) and the iodide (3-iodopropane-1,2-diol) were
Figure 6. TLR2 agonists in BMDC is crucial for IL-6 and IL-12 production. (A) IL-6 and IL-12p40 production by wild-type but not TLR22/2
BMDC by Pam2Cys stimulation. BMDC prepared from wild-type or TLR22/2 mice were treated with indicated Pam2Cys peptides (100 nM) for 24 h.
IL-12p40 and IL-6 concentrations in the supernatants were determined by ELISA. (B) Pam2Cys13(P-S) but not Pam2Cys13 induces IL-6 and IL-12 from
BMDC. BMDC prepared from wild-type mice were treated with indicated Pam2Cys peptides (100 nM) for 24 h as in panel A. Cytokines in the
supernatants were determined by ELISA. 13S, Pam2Cys13(P-S); 15SN, Pam2Cys15(LI-SN).
doi:10.1371/journal.pone.0012550.g006
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Cys(2,3-dihydroxypropyl)-OtBu, and the subsequent acylation and
cleavage of the tBu group gave Fmoc-Pam2Cys-OH [37]. The
peptide component, which included 16 different peptide sequences
from 14 lipoproteins of S. aureus NCTC8325, was prepared by
using solid-phase synthesis on Wang resin in a similar fashion to
Jung’s lipopeptide synthesis. Fmoc-Pam2Cys-OH [30,37] was
then introduced to the N terminus of the peptides linked to the
resin. Subsequent cleavage of the Fmoc group, detachment from
the resin, and deprotection of all protecting groups gave the
lipopeptides Pam2Cys1–16, and also Pam2CSK4. Pam2CSK and
Pam2CSK2 were obtained from Biologica Co. Ltd. Commercial
and our synthetic Pam2CSK4 had indistinguishable potential for
BMDC maturation and cytokine production (data not shown).
Mouse and cell lines
TLR2 2/2, TLR4 2/2, and MyD88 2/2 mice were gifts
from Dr. S. Akira (Osaka Univ., Osaka) as previously reported [9].
Figure 7. BMDC-NK cell contact induces NK activation. (A) IFN-c induction by NK cells requires BMDC-NK contact. BMDC prepared from wild-
type mice were treated with indicated Pam2Cys peptides (100 nM) for 4 h. Then, BMDC were incubated with naı ¨ve NK cells for 24 h at the ratio of 1:2
(left hand bars in Contact). The level of IFN-c was measured by ELISA. Of note, the sup of the stimulated BMDC was collected and added to cultures of
unstimulated BMDC and naı ¨ve NK cells, but only a minute level of IFN-c was detected in the sup (data not shown). The levels of IFN-c in the same
combinations are shown (right hand bars in Trans-well) when stimulated BMDC and NK cells were separated by trans-well. 13S, Pam2Cys13(P-S);
15SN, Pam2Cys15(LI-SN). (B) %IFN-c-positive NK cells were determined by intracellular staining. Wild-type BMDC prepared from C57BL/6 mice were
treated with Pam2Cys13(P-S) peptides (100 nM) for 4 h as in panel A. Then, wild-type NK cells were added to the wells. 20 h after co-culture,
breferdin was added to the wells and incubation was continued further for 4 h. NK cell activation was determined by IFN-c produced in NK cells.
%IFN-c-positive NK cells was determined by FACS.
doi:10.1371/journal.pone.0012550.g007
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our laboratory [4,33]. Female C57BL/6 mice were purchased
from Clea Japan (Tokyo). Mice were maintained in our institute
under specific pathogen-free conditions. All animal work was
performed under guidelines established by the Hokkaido Univer-
sity Animal Care and Use Committee. This study was approved as
Analysis of immune modulation by toll-like receptors by this
committee. Mice (12 weeks female C57BL/6) were housed four
per cage and allowed food and water ad libitum. The Ethics
committee in Hokkaido University approved this study (ID
number: 08-0243). Animal studies were carefully performed
without ethical problems.
B16D8 were established in our laboratory as a subline of the
B16 melanoma cell line [38]. This subline was characterized by its
low MHC levels with no metastatic properties when injected s.c.
into syngeneic C57BL/6 mice [4,33]. HEK293 and B16D8 cell
lines were obtained from ATCC (USA). These cell lines were
cultured in RPMI 1640/10% FCS.
Preparation of BMDCs and spleen NK cells of mice
Mouse bone marrow-derived DC (BMDC) were prepared as
described previously [4]. Spleen NK cells were positively isolated
from spleens with DX5 Micro Beads (Miltenyi Biotech) [33]. In
experiments requiring high purity NK cells, Thy1.2 beads were
additionally used for negative selection according to the Miltenyi’s
protocol. The purity of NK cells (DX5
+ cells) was routinely about
70%. NKT cells might be an only trace constitution of our
preparation. DX5
+ NK cells were used within 24 h.
Reporter assay
Plasmids (pEFBos) for expression of human TLR1, TLR2,
TLR6 and TLR10 were prepared in our laboratory as described
previously [39]. HEK293 cells were seeded onto 24-well plates and
transfected with 0.1 mg TLR expression vectors, 0.1 mg of ELAM-
1, and 0.05 mg of phRL-TK control plasmid using FuGene HD
(Roche) according to the manufacturer’s instructions. The ELAM-
luciferase reporter plasmid was made in our laboratory [13]. After
24 h, the cells were harvested in 50 ml lysis buffer. The luciferase
activity was measured using Dual-Luciferase Reporter assay
systems (Promega) and was shown as the means 6 S.D. of at
least three experiments.
Statistical analysis
Student’s t test was used to examine the significance of the data
when applicable in quantitative studies. Differences were consid-
ered to be statistically significant when P,0.05.
ELISA, Flow cytometric (FACS) analysis of cell surface
antigens
The levels of cytokines (IL-6, IL-12p40, IFN-c etc.) were
determined by sandwich ELISA (Amersham Pharmacia Biotech,
Buckinghamshire, UK) or the message levels assessed by
quantitative PCR [38]. Surface CD25, CD86 and CD69 levels
were determined by FACS using specific mAbs. The practical
methods for FACS were described previously [40]. Intracellular
staining of IFN-c was peformed with breferdin-treated NK cells as
described previously [39]. Trans-well analysis was performed as
described previously [40]. Assays were usually performed at least
three times in duplicate, otherwise indicated in the legends, and
one representative experiment is shown.
Assessment of in vitro cytolytic activity
The cytolytic activity of spleen NK cells was determined by
51Cr
assay as described previously [4,33]. NK cells were prepared from
the spleen of intact C57BL/6 mice. NK cells were co-cultured
with BMDCs at a ratio of 2:1 and 24 h later the mixtures were
subdivided to assess NK-mediated cytotoxicity [4]. A B16 subline
(D8) or YAC-1 was used as a target cell. Target cells (2610
3 cells/
well) were coincubated with NK cells at the indicated lymphocyte
to target (E/T) cell ratio (typically 5, 15 and 30) in U-bottom 96-
well plates in a total volume of 200 ml of 0.5% BSA/RPMI-1640
medium at 37uC. Four hours later, the liberated
51Cr in the
medium was measured using the scintillation counter. Specific
cytotoxic activity was obtained by the formula: Specific cytotoxic
activity (%) =[(experimental
51Cr activity - spontaneous
51Cr
activity)/(total
51Cr activity – spontaneous
51Cr activity)] 6100.
Each experiment was done in triplicate to confirm reproducibility
of the results, and representative results are shown. t test was used
to examine the significance of the data.
Supporting Information
Figure S1 Direct activation of NK cells by stimulation with
Pam2Cys12, 18 or 19. Wild-type or TLR22/2 NK cells (56105
cells/well) were stimulated with indicated Pam2Cys peptides for
24 h. After 24 h, IFN-c concentrations in the supernatants were
measured by ELISA as in Fig. 2A. The IFN-c concentrations were
more than 5-fold lower than those in the mixture of BMDC and
NK cells (see Figs. 2A and 3).
Found at: doi:10.1371/journal.pone.0012550.s001 (0.08 MB TIF)
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